About Odevixibat (equivalent to odevixibat sesquihydrate (0.622 mg)
            
            Class: | Bile acid transport inhibitor  
Use: | Treatment of progressive familial intrahepatic cholestasis (PFIC) in patients 3 months of age and older  
Adult dose: | Not established; primarily used in pediatric populations  
Pediatric dose: | Initial dose of 0.5 mg/kg once daily, may be increased to a maximum of 1 mg/kg once daily based on clinical response and tolerability  
Side effects: | Diarrhea, abdominal pain, nausea, fatigue, and elevated liver enzymes  
Contraindications: | Hypersensi
         
        
            
                
                
                    
                        Drug Class
                    
                    Bile acid transport inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of progressive familial intrahepatic cholestasis (PFIC) in patients 3 months of age and older
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: IPSEN PHARMA [ Boulogne- Billancourt;France], France
                    
                    
                    Package Size
                    30's HDPE Bottle
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 57775.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Not established; primarily used in pediatric populations
                    
                    
                        Pediatric Dose
                    
                    
                        Initial dose of 0.5 mg/kg once daily, may be increased to a maximum of 1 mg/kg once daily based on clinical response and tolerability
                    
                 
                
                
                    
                        Side Effects
                    
                    Diarrhea, abdominal pain, nausea, fatigue, and elevated liver enzymes
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to odevixibat or any component of the formulation; severe liver impairment
         
        
        
            
                Important Warnings
            
            Risk of liver injury; monitor liver function tests prior to and during treatment; not recommended for use in patients with severe hepatic impairment
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.